Log in
Enquire now
‌

ErVimmune

ErVimmune is a cancer vaccines developer founded in 2019.

OverviewStructured DataIssuesContributors

Contents

ervimmune.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Health technology
Health technology
Pharmaceutical industry
Pharmaceutical industry
Biotechnology
Biotechnology
Number of Employees (Ranges)
11 – 50
Email Address
contact@ervimmune.com
Investors
Seventure Partners
Seventure Partners
SPRIM Global Investments
SPRIM Global Investments
Founded Date
2019
Total Funding Amount (USD)
20,000,000
Latest Funding Round Date
January 21, 2026
Latest Funding Type
Series A
Series A
Country
France
France
Headquarters
Lyon
Lyon

Other attributes

Latest Funding Round Amount (USD)
20,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like ErVimmune

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.